The paper examines the Europeanization process and the impact of the European Union (EU) on national healthcare policies. The analysis reveals that although health policy formally falls within the competence of member states, the impact of the EU is becoming increasingly conspicuous and has contributed to a gradual restructuring of healthcare boundaries as well as some of its organising principles. Furthermore, the process and impact have a de-structuring effect on the more traditional governance tools used in relation to healthcare. The paper concludes that the EU has a significant impact and that we may be witnessing the formation of a new institutional legacy that represents the initiation of a Europeanised healthcare model: a model emerging around a new set of stakeholders, principles and structures, which include the market, principles of free movement, patient choice and patient rights institutionalised and safeguarded by the EU.
Introduction
This paper examines the impact of the European Union (EU) on Danish healthcare to identify the effect of the EU on a policy field which is formally regarded as falling within the realm of national therefore also hold in relation to healthcare policy. However, it is a 'less likely case' for Europeanization, since the Treaty explicitly sets out that healthcare is a member state competence (for further discussion of the methodological and theoretical value of working with 'least likely' cases, see Eckstein (1975) ). It is a critical case, because healthcare is formally regarded as a member state competence, where EU-induced change should not be expected. Furthermore, examining the meeting between EU principles and rules and the specific Danish case highlights the impact of the EU on systems organised as national health services (NHS) , which in addition to Denmark counts the other Nordic member states, the UK, Ireland, Italy, Spain, Portugal and Greece.
NHS systems were previously held to be sheltered from EU interference, as they offer healthcare as benefits-in-kind, free of charge, tax-financed and publicly supplied. Due to the characteristics of the national health service model, it was regarded as exempted from the Treaty's understanding of 'service' (Section 5 below).
To the best of our knowledge, the impact of the EU on NHS systems has not previously been investigated in terms of process-tracing research from a political science and public administration perspective. The research for this paper includes different sets of interviews; 1) primarily with key respondents in the Danish Ministry of Interior and Health at several stages of the Europeanization process; 2) interviews conducted in the UK Department of Health to compare the findings of the Danish case; and 3) interviews in the European Commission, Unit of Coordination of Social Security. Furthermore, the research consists of documentary studies drawing on information from the archive of the Danish parliament in an attempt at quantifying the impact (see Section 3 below), parliamentary questions, debates and governmental notes. Both the interviews and the documentary study have served to separate national and EU influences on the identified healthcare reform process. On the basis of the research that has been carried out, the paper concludes that the EU is having an increasing impact on the organisation and governance instruments of national healthcare including those belonging to an NHS systemto the extent that it is possible to perceive a gradual restructuring of the contours and boundaries of healthcare as well as some of the organising principles and tools of governance.
In addition to the introduction and conclusions, this paper consists of five substantive sections. In Section 2, we discuss theoretical issues that arise when researching the dynamics and impacts of Europeanization. Section 3 presents a quantitative examination of the impact. The subsequent sections examine the contemporary governance of Danish healthcare, focusing in particular on the issues of patient choice and free movement. Section 4 outlines the key characteristics of Danish healthcare and details recent reforms with relevance to EU integration. Section 5 describes the new external, i.e. EU-driven, boundaries to the policy field with specific focus on healthcare integration formed through the influence of the EU internal market; while Section 6 examines the Europeanization of Danish healthcare. Finally, some concluding remarks are presented about the Europeanization of Danish healthcare as the outcome of the interface between national and supranational processes of change.
Researching the Dynamics and Impacts of the EU
The study of Europeanization aims to understand and explain both the processes of change that national policies, politics and polities undergo as a result of EU integration together with the specific impact resulting from EU integration. According to the definition by Radaelli, Europeanization involves both a process through which formal and informal rules are first defined and consolidated at the EU level and then incorporated in the domestic discourse, political structure, and public policies (Radaelli 2003, p. 30; Bulmer & Radaelli 2005, p. 341) . The focus of the present study concerns the Europeanization process and impact of European integration on national healthcare policy.
However, it is important to set off by clarifying the European cause that drives Europeanisation (Smith 2002) . Healthcare integration is characterised by a fragmented degree of coerciveness. As a field of integration, healthcare is institutionalised in a scattered way, in the sense that it lacks the binding knots of political commitments. However, it is a field of integration which demonstrates the powerful role of law in transcending high spirited, but inconcrete, principles, such as the free movement of services and Union citizenship, into effective tools of governance. Thus law, through the creative and teleological interpretations of the European Court of Justice, appears to be a functional tool in adding and expanding dimensions of the European polity (De Búrca 2005; Stone Sweet et al. 2001; Mattli and Slaughter 1998 (Schmidt 2002; Haverland 2000; Börzel 1999 Börzel , 2005 Falkner et. al 2005) . Some may facilitate the process of Europeanization while others limit it.
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The present study will identify two mediating factors which are decisive to the Europeanization of healthcare. The first constitutes a veto-point and is the way in which the national administration (re)interprets EU-relevant decisions for health. This veto-point limits Europeanization from the start, as it provides the national administration with interpretive discretion hindering the full impact of EU integration. However, the analysis will point out that such a veto-point is dynamic, and the national discretionary scope may narrow as EU integration continues. The second mediating factor concerns institutional legacy, but from the perspective of domestic reform. It thus opens up a dynamic perspective on institutional legacy, as even heavily institutionalised policies undergo change. In the present case, the domestic reform undertaken supports the principles in the integration process. Due to congruence between the steps of integration and those contained in the national reform, this mediating factor facilitates Europeanization.
In general research, Europeanization is likely to be complicated by the fact that both independent and mediating variables are simultaneously in flux, i.e. it involves examining the effect of a dynamic cause transmitted by dynamic national institutions. In this way, Europeanization takes place as result of multiple influences rather than simply as a top-down EU-imposed or induced process of change. 
Figure 1: The Europeanization of Healthcare Policy
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As Figure 1 illustrates, we expect a certain degree of institutional change to take place as a result of Europeanization. However, the extent and eventual further effect of EU-induced change will not be detailed here, but on the basis of the following analysis.
This leads us to another challenge confronting the study of Europeanization: how do we measure the degree of change caused by European integration. For the future development of theory, it is essential that it is possible to measure the diverse impacts of the EU. Analysing the degree of European-driven change can be undertaken at a conceptual leveldifferentiating between retrenchment, inertia, absorption, accommodation and transformation, where the progression towards transformation signifies a greater degree of EU-induced change (Börzel 1999; 2005, pp. 58-59; Radaelli 2003, pp. 37-40) . Although such description remains at the conceptual level, it is useful for labelling degrees of change. Relying on the methodological characteristics of the present case as a 'less likely' case of Europeanization, we should either expect inertia or only a slight degree of change; i.e. absorption. However, the mediating factors may propel or even retrench the effect of EU integration.
The following analysis will first address whether the impact of the EU can be measured quantitatively. Subsequently, it will continue by conducting a qualitative process-tracing study.
The Quantitative Measurement of Impact
A precise and quantitative measurement of EU impact on specific policies would ideally serve the objective to ascertain the extent to which the EU reaches into the domestic realm. However, quantitative impact data are limited. Nevertheless, the archive of the Danish parliament makes it possible to quantify impact to some extent. Methodologically, we have examined the explanations attached to each legislative proposal on health policy in the archive of the Danish Parliament (Folketinget) to determine whether the proposal makes reference either to EU regulations or had been proposed in order to implement EU law. The archive provides data for the parliamentary years 1997-2005. Our analysis only investigates those proposals which were later adopted by the parliament.
Our dataset covers the Danish proposals which made reference to either EU 'soft' or 'hard' law, including measures beyond those that member states are legally bound to implement. Thus, the scope not only includes the laws that -partly or fully -aim to implement an EU directive, as well as those which simply refer to EU obligations in a broad sense. Implementation can be regarded as substantive Europeanization, whereas reference is likely to be largely formalistic. During the years covered in the data (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) approximately nine percent of the adopted proposals were proposed in order to implement an EU directive, while around 23 percent made reference to EU regulation.
The quantitative data show that between 1997 and 2005, an average of roughly 23 percent of Danish healthcare legislation was influenced by or referred to EU law. Figure 2 shows that the impact of the EU was greatest, at 33 percent, during both the 1998-1999 and 2000-2001 parliamentary sessions and lowest during that of 1997-98, during which time none of the national laws adopted were influenced by EU rules. 
Percentage of adopted proposals with reference to EU regulation
Returning to substantive Europeanization, an average of nine percent of Danish healthcare legislation that represented the implementation of EU law is indeed considerable for a policy field which, formally regarded, is national competence. However, it may only mirror part of Europeanization. The dataset merely indicates those proposals that were introduced by legislation and does account for the EU regulations that the Danish Executive chose to introduce via administrative means, such as departmental orders and circulars. Indeed, substantive
Europeanization may be introduced via this route. Furthermore, the quantitative analysis leaves out all of the EU-related changes that were not the consequence of Community directives. This is because Treaty provisions and regulations have a direct effect and are therefore not normally implemented through the national legislative process. Furthermore, Community 'decisions' are also excluded, as they only regulate specific parties or situations. Finally, the impact of the ECJ case law may be dispersed, as it is not generally implemented via laws but may nevertheless have significant impact and influence on administrative practices, legal reasoning and future policy reform (Martinsen 2005) .
Other EU impacts may only be uncovered through a qualitative process-tracing study (Checkel 2005) , which we will now undertake, first by outlining the key characteristics of the Danish healthcare system, then by mapping the emerging contours of EU-driven developments in the policy field, and finally examining the Europeanization of Danish healthcare.
Danish Healthcare; Characteristics and Recent Reforms
Danish healthcare can be characterized as a decentralized, public, integrated healthcare system.
Responsibility for organizing and delivering services is placed in the hands of 5 decentralized, democratically elected, assemblies at regional level, while the 98 municipalities have responsibility for an number of prevention and rehabilitation services. The system is integrated in the sense that both financing and delivering secondary level services are public responsibilities. Primary care services are provided by mainly private practitioners, but publicly funded and integrated in regional planning. The regions operate within a framework of national legislation and annual agreements with the national level and biannual agreements with professional groups concerning financial arrangements and service delivery.
The public healthcare system guarantees universal health coverage for all persons residing in Denmark. However, the general principle of territoriality implies that entitlement to Danish healthcare ends at the national border (Cornelissen 1996; Martinsen 2005) .
Treatment is provided free of charge and general practitioners serve as gate keepers to hospital services. There are co-payments, mainly for pharmaceuticals, dentistry and physiotherapy, but with exemptions for chronically ill and low-income groups. There is a strong emphasis on equity in terms of rights to the same treatment for the same condition, regardless of social status, age, geography or ability to pay. The system is financed through taxation (a fixed health contribution of 8 percent of taxable income), which is redistributed to regional and municipal authorities as a combination of block grants and activity based contributions. Municipalities co-finance health services delivered by the regions.
National policy reforms
A number of changes have been implemented in the Danish healthcare system during recent decades. In general, they can be characterized as gradual adjustments rather than fundamental reforms (Pedersen et al 2005, Vrangbaek and . However, two trends with particular relevance for the analysis of Europeanization appear to have had a more profound impact over time. The first is the introduction of market elements and particularly patient choice, which is relevant for the discussion of free movement of goods, services and persons in the EU. The second is an ongoing trend toward centralization in both policy making and administration (Salomonsen 2005, Vrangbaek and Martinsen 2005) . The centralization trend culminated in the decision on structural reform which was implemented January 1 st 2007. The reform has changed the financing system (see above), has redistributed tasks and has reduced the number of regional authorities from 14 counties to five regions (0,6-1,6 million inhabitants) and the number of municipalities from 275
to 98 -with a population range from under 20,000 (less than seven percent of the new municipalities) to over 50,000 (37 per cent of the new municipalities A choice of 'insurance' plan for access to general practice and specialists has been in place since the early 1970s. Most Danes choose 'Group I' coverage, which, once registered with a specific General Practitioner (GP), provides free GP and specialist services and GP controlled access to specialists and hospital treatment. Patients may change their GP registration at regular intervals, free of charge, or between periods for a nominal payment. 'Group 2' coverage provides direct access to specialists for a co-payment. This option is chosen by only around three per cent of the population.
A policy providing a 'free choice of hospital' was introduced in 1993. Under this scheme a patient, once referred by a GP, may choose to have their treatment at any public hospital and some private not-for-profit hospitals at the same level of specialisation. An 'extended free choice' was introduced in 2002. This is linked to a treatment, or waiting time, guarantee and provides access to a range of contracted private and some foreign facilities, when patients are faced with an anticipated waiting time in the public health system that exceeds two months. The scheme is designed to increase the service level by putting pressure on public providers, as the counties/regions are obliged to pay for services delivered in public or private hospitals outside their own jurisdiction. The waiting time guarantee institutionalizes the principle of access to private or foreign treatment facilities in cases of 'undue delay' in the national system. The waiting time will be reduced to 1 month as of October 2007. However, the Danish government maintains that the regions have the right to limit treatment abroad to selected facilities with which they hold a contract. This will be examined in more detail in section 6 below.
There appears to have been a slightly increasing trend in the use of both types of choice. Official The relatively limited use of the 'free choice' schemes reflects the generally short waiting times in Denmark, although variations in waiting times nevertheless persist. Preferences for treatment close to home, travel costs, custom and limited information on quality of provision may be other explanatory factors for the pattern of use (Vrangbaek et al. 2006; Vrangbaek 1999) .
A Danish Diagnosis Related Groups (DRG) classification system for treatments and related pricing has been developed from the late 1990s. This has enabled a number of experiments with activitybased financing as a supplement to the regular block grants and global budgets. 'Free choice' patients across county lines are paid on a full DRG price basis. In most cases this has created incentives for counties to try to retain patients by reducing waiting lists.
In terms of healthcare policy debates, the role of the EU has so far been little debated. Adjustments to EU initiatives have mainly been treated as technical matters that have not given rise to major parliamentary or public debate. Within the health policy community some attention has been given to the development of the Service Directive, but as it became clear that this would not include healthcare the interest waned. Substantive EU impacts on healthcare have thus taken place rather discretely, insulated from wider debate.
New external health boundaries
At the same time as it undergoes domestic change, Danish health policy is increasingly affected by the initiatives and decisions of the European Union. National health policies are affected by EU intervention via different routes. While member state governments have for long held that they have full responsibility and control over their own health services, it is becoming increasingly clear that the Single European Market is having a substantial impact.
Assessing the specific competencies of the EU within the area of health is a complex task. On the one hand, article 152 of the Treaty states that the EU has certain competencies in securing a high level of public health but at the same time caveats this that "Community action in the field of public health shall fully respect the responsibilities of the Member States for the organisation and delivery of health services and medical care" (Article 152 (5) However, in a series of judgement from 1998 and onwards, the ECJ has questioned the justification for 'prior authorisation' and has gradually established that the principles of the internal market also apply to health policy (see Martinsen 2005b for a more detailed describtion of the series of judgements  The decision on whether or not to grant treatment abroad is based on "international medical science";
 And an equivalent treatment can be provided in the competent member state without "undue delay" taking into consideration the medical condition of the patient, broadly defined.
The ECJ later proceeded with its proactive course by introducing a distinction between hospital and non-hospital care (C-385/99, Müller-Fauré & Van Riet, 13 May 2003) . In the case of hospital care, the Court restated its view that the requirement for prior authorisation is justified on condition that it is exercised proportionately and that a national treatment can be provided without 'undue delay.
The matter was, however, quite different for non-hospital care. The Court laid down that national authorisation constitutes an unjustified barrier to the free movement of services for non-hospital care. Given the increasingly blurred distinction between hospital and non-hospital care, the future implications of this judgement are likely to be extensive. In 2006, a new contribution to the integration of healthcare was produced. In the recent case of Watts, the Court applied its line of reasoning to a National Health system, and considered for the first time the free movement of services principle against a health system providing treatment free of charge, publicly organised and funded through general taxation (C-372/04, Watts, 16 May 2006). In its judgement, the ECJ confirms, and indeed furthers, its previous line of health related judgements. The conclusions remove the scope for national institutions to exercise administrative discretion and bring the rights of the European patient into sharper focus. In so doing, it intervenes in the national sphere of governance. Furthermore, the Court equips the European patient with institutional structures to claim those rights. It frames the right to appeal.
The European Patient in Focus
The Court repeated that all medical services are 'services' within the meaning of the Treaty:
"It should be noted in that regard that, according to settled case-law, medical services provided for consideration fall within the scope of the provisions on the freedom to provide services […] there being no need to distinguish between care provided in a hospital environment and care provided outside such an environment (para 86 of the judgment).
The Court thus clarified that the characteristics of the UK National Health Service do not exempt it from EC law. Article 49 of the Treaty applies regardless of the way the national system is organised (para 90 of the judgement). The general applicability of the Court's previous judgements is affirmative.
The central issue being that of waiting time, it is crucial to note that although the Court does not specify when a waiting time for a particular treatment can be considered to be 'undue delay', it sets out a (reviewable) criterion for determining whether a period of waiting time is acceptable in the context of EC law. Waiting time must not:
"exceed the period which is acceptable on the basis of an objective medical assessment of the clinical needs of the person concerned in the light of all of the factors characterising his medical condition at the time when the request for authorisation is made or renewed, as the case may be" (para. 79 of the judgement).
The Court went on to specify the institutional structures that member states must provide to protect the rights of the European patient. The Court repeats the conclusions from its previous judgements, stating that the requirement for prior authorisation cannot legitimise discretionary decisions by national authorities, but must be based on objective, non-discriminatory, criteria and allow for decisions on authorisation to be challenged in judicial or quasi-judicial proceedings (paras. 115-116) . Notably, the Court goes beyond a restatement of precedent and extends member states' obligation to provide transparency and legal certainty to European citizens:
"To that end, refusals to grant authorisation, or the advice on which such refusals may be based, must refer to the specific provisions on which they are based and be properly reasoned in accordance with them. Likewise, courts or tribunals hearing actions against such refusals must be able, if they consider it necessary for the purpose of carrying out the review which it is incumbent on them to make, to seek the advice of wholly objective and impartial independent experts" (para 117 of the judgement).
The Watts case is a further judicial step strengthening the position of the European patient. Not only has s/he been granted rights beyond the national borders, but s/he has also been provided with a structure and judicial procedures through which to bypass the national system or challenge its decisions. In essence, the judicial activism of the ECJ has provided the Union citizen with new exit but also new voice opportunities beyond the national system. The response to this judgement by EU citizens, private interests, national courts and member state governments will decide the next steps 
The Europeanization of Danish Healthcare
The impact of the judicial interpretations of the principles of the internal market on Danish health policy, while clearly visible, can be described as diffuse and restrained. Denmark is one of the member states, which has responded to the development of caselaw by partially integrating the foreign supply of goods and services. This implementation has effectively broken down the principle of territoriality in healthcare. While Denmark took this initial step to respond to developments in ECJ case law concerning healthcare goods and services outside the hospital sector, domestic reforms and initiatives, were also moving along similar lines. As shown in section 4 above, these national reforms introduced a greater element of market competition into demand for healthcare by increasing patient choice, while at the same time centralising governance and control of supply. These processes have also facilitated the introduction of the dynamics of Europeanization into the hospital sector.
Denmark took an active stance in the subsequent case of Geraets-Smits and Peerbooms, being among the governments that intervened to give an opinion. The Danish opinion restated the conclusions of the Decker/Kohll report (Interview, Danish Ministry of Health, 3 April 2001) that, due to the absence of remuneration, hospital treatment did not constitute a service within the meaning of Treaty Article 50 (Report for the Hearing, pp. 76-77). Beyond making this point, Denmark argued that another precondition for a service to be Treaty-related was that it must be provided with a view to making a profit (Report for the Hearing, p. 78).
The Court, however, disagreed with these observations and extended the understanding of 'remuneration' in Treaty Article 50 to include indirect payments such as those transferred by social security funds to cover healthcare costs (Hatzopoulos, 2002, p. 693 
Concluding Remarks
Although diffuse, the EU impacts on NHS systems are many and far-reaching. The more significant effects are the re-structured boundaries for the organisation of the policy field; an increased obligation for the member states to integrate foreign suppliers into the domestic healthcare mix; and a de-structuring of the traditional tools of governance.
The process involved in the Europeanization of Danish healthcare has been transmitted by two types of mediating factors. The Danish administration has played a key role, since it has constituted the most significant veto-point in the process, occupying the space of control through which the ECJ decisions have been re-interpreted and 'translated'. On the one hand, the administration has allowed a certain impact. At first glance, it has proven its reputation as complier with EU obligations (Falkner et al. 2005 ). On the other hand, it has attempted to steer and reduce the effects of the EU on Danish healthcare. The administration has defended its discretionary scope by maintaining a definition of service, which de facto goes against the definition developed by the ECJ. In this way, impact has been reduced. Furthermore, its implementation of the new exit option to allow foreign treatment to patients if they cannot be treated nationally without 'undue delay', i.e. 2 months as of now (one month as of October 2007), is not simply the implementation of unrestricted free choice.
Through the means of contracts, control remains in the hand of the Danish administration, and de facto foreign hospitals are not treated equally with private and public hospitals established in Denmark.
The manner in which the Danish executive exercises its veto-point through a creative and autonomy-preserving re-interpretation of the meaning of ECJ decisions comes to limit the full impact of EU integration. Nevertheless, the other mediating factor, domestic healthcare reforms,
introduces new principles in Danish healthcare governance. This indeed propels Europeanization, as the congruence between the paths of national reforms and that of EU healthcare integration is high.
Free choice of hospital, waiting time guarantees, the free movement of Union citizens and services and an intensified focus on patient rights all go hand-in-hand and facilitate the Europeanization process.
The concrete impact is a result of these two contradicting mediating factors. Among the impacts are legislative amendments integrating both non-hospital and hospital foreign supplies, thus indeed restructuring the traditional boundaries of Danish healthcare. The principle of territoriality as a tool of healthcare governance has been compromised, and its future legitimate exercise is called into question by the supranational polity. This has significant implications for governance. Whereas the state and counties traditionally controlled the supplyand thus the organisation and quality of healthcarefree choice introduces a very different logic of governance. Free choice has a clear analogy to the market, and its logic is backed up by patient rights. The customer, i.e. the patient, decides. And via an EU exit opportunity, the healthcare market will become immense as compared with the national healthcare systems of the presentwhen the member states implement their European obligation in full scope. Furthermore, the EU polity provides the Union citizen with voice, should her rights be violated. Not only can the Union citizen rely on the EU judicial system, but the interpretations of the ECJ oblige the member states to administer EU rights transparently, objectively and provide appeal structures if the welfare supply of other member states is denied.
Against this background, it is also clear that the governance tool of administrative discretion is severely challenged. Exit opportunities, as supported by EU-institutionalised voice (Hirschman 1970; Ferrera 2005; Bartolini 2005 ), de-structure the traditional means of healthcare governance, and the logic introduced places the ultimate (and smallest) unit in the system in focus: the EU citizen, the patient, the welfare consumer. Their (free) welfare movements may prove difficult to govern. In spite of healthcare as a 'less likely' case of Europeanization, impact goes beyond the light mode of absorption. Healthcare is being made to accommodate the European principles affecting the traditional means of governance and organisation. Future impact may scale beyond accommodation. We may witness the formation of a different institutional legacy, initiating a Europeanised healthcare model. A model emerging around a new set of stakeholders, principles and structures, which includes the market, principles of free movement, patient choice and patient rights institutionalised and safeguarded by the EU.
